Independent evidence before payment.
Each compound is graded on the strength of published evidence, with human, animal and in-vitro tiers never merged. This is about the state of the evidence — not how to use anything. No dosing, no protocols.
The Evidence Grade rates only the strength of published evidence — human, animal and in-vitro kept strictly separate — not safety or efficacy. A = two or more confirmatory human RCTs, down to F = lab-bench evidence only.
GHRH analogue
Thymosin beta-4 fragment
Long-acting amylin analogue
Synthetic peptide fragment
GH fragment analogue
Coenzyme / metabolic cofactor
GHRH analogue
Mitochondria-targeted peptide
Synthetic tetrapeptide
GLP-1 receptor agonist
Triple GIP/GLP-1/glucagon agonist
Melanocortin receptor agonist
GHRH analogue
Mitochondrial-derived peptide
Oral GH secretagogue (non-peptide)
Growth hormone secretagogue (GHRP)
Copper-binding tripeptide
Neuropeptide
Anti-inflammatory tripeptide
Small-molecule NNMT inhibitor
Synthetic heptapeptide
Dual GIP/GLP-1 receptor agonist
Melanocortin receptor agonist
Immunomodulatory peptide
Synthetic peptide (ACTH fragment analogue)